Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune endocrine disease

J R Baker

    JAMA
    |December 13, 1997
    PubMed
    Summary
    This summary is machine-generated.

    Autoimmune endocrine diseases like type 1 diabetes mellitus cause significant disability. Research into their complex causes offers hope for targeted treatments beyond hormone replacement therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    An efficient synthesis of epoxydiynes and a key fragment of neocarzinostatin chromophore.

    Organic letters·2006
    Same author

    Acute and chronic gas bubble lesions in cetaceans stranded in the United Kingdom.

    Veterinary pathology·2005
    Same author

    Stress management. Stress, like pain, is inevitable--suffering is optional.

    The Journal of the Arkansas Medical Society·2005
    Same author

    Central neuropeptide B administration activates stress hormone secretion and stimulates feeding in male rats.

    Journal of neuroendocrinology·2004
    Same author

    Deformability of poly(amidoamine) dendrimers.

    The European physical journal. E, Soft matter·2004
    Same author

    Diagnostic delays of adult patients admitted to hospital with diabetic ketoacidosis.

    Diabetic medicine : a journal of the British Diabetic Association·2004
    Same journal

    WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

    JAMA·2026
    Same journal

    FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

    JAMA·2026
    Same journal

    HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

    JAMA·2026
    Same journal

    US Dietary Supplement Use Increasing, Especially in Older Adults.

    JAMA·2026
    Same journal

    Heat Stress From Climate Change Surges Globally.

    JAMA·2026
    Same journal

    Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

    JAMA·2026
    See all related articles

    Area of Science:

    • Immunology
    • Endocrinology
    • Genetics

    Background:

    • Autoimmune endocrine diseases represent a significant health burden, encompassing conditions such as type 1 diabetes mellitus, thyroiditis, Graves disease, Addison disease, and polyglandular syndromes.
    • These disorders consume substantial healthcare resources and lead to considerable patient disability.

    Purpose of the Study:

    • To summarize the current understanding of autoimmune endocrine diseases.
    • To highlight recent advancements in immunologic physiology aiding disease analysis.
    • To discuss current and future therapeutic strategies.

    Main Methods:

    • Review of recent investigations applying immunologic physiology to study autoimmune diseases.
    • Analysis of genetic predispositions and varied pathogenesis.

    Related Experiment Videos

  • Evaluation of current treatment modalities and future therapeutic prospects.
  • Main Results:

    • Autoimmune endocrine diseases exhibit complex pathogenesis and intricate genetic underpinnings.
    • New knowledge in immunologic physiology has been crucial in dissecting these disorders.
    • Current treatments primarily involve hormone replacement for damaged endocrine organs.

    Conclusions:

    • Understanding the pathogenesis of autoimmune endocrine diseases is key to developing specific therapies.
    • Future research holds promise for treatments that target the underlying pathology, moving beyond symptomatic management.